| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.019 | 0.7 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.017 | 0.7 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.012 | 0.8 |